"The Diabetes Institute is the first of its kind in the Pacific Northwest, integrate advanced care for patients with all types of diabetes, including Type 1, Type 2 and more unusual forms of diabetes that may develop in conjunction with other medical conditions and/or treatments. We also provide specialty care for patients with diabetes, including cardiology, weight loss, nephrology and podiatry. Located in a new, state-of-the-art building on UW Medicines South Lake Union campus, the Diabetes Institute brings together research and clinical care."

During the past decade, University of Washington, Diabetes Care Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Washington, Diabetes Care Center" #1 collaborator was "Aventis Pharmaceuticals" with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "The Leona M. and Harry B. Helmsley Charitable Trust" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Washington, Diabetes Care Center" are "Diabetes Mellitus, Type 1" (1 trials), "Diabetes, Type 1" (1 trials), "Type 1 Diabetes Mellitus" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "University of Washington, Diabetes Care Center" in a lesser frequency.

Most popular intervention types in "University of Washington, Diabetes Care Center" are "Drug" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexcom CGM" (1 trials), "Insulin glargine" (1 trials), "Insulin lispro" (1 trials), "Internet co-management module" (1 trials) and "Technosphere Insulin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Washington, Diabetes Care Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "University of Washington, Diabetes Care Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Washington, Diabetes Care Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Washington, Diabetes Care Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".